(WASHINGTON) — In allowing President Trump’s revised travel ban to partially take effect, the Supreme Court left key questions unanswered and likely opened the floodgates for additional litigation. In ...
Drug manufacturers remain steadfast in their efforts to challenge the constitutionality of the Inflation Reduction Act’s mandatory price negotiation provisions. Recently filed suits contend that CMS ...
The Federal Motor Carrier Safety Administration issued final regulatory guidance on June 16 clarifying the definitions of “broker” and “bona fide agents,” and the extent to which “dispatch services,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results